• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD POSIFLUSH¿ PRE-FILLED SALINE SYRINGE; SALINE, VASCULAR ACCESS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD POSIFLUSH¿ PRE-FILLED SALINE SYRINGE; SALINE, VASCULAR ACCESS FLUSH Back to Search Results
Catalog Number 306575
Device Problem Volume Accuracy Problem (1675)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/28/2023
Event Type  malfunction  
Manufacturer Narrative
B.3.Date of event: unknown.The date received by manufacturer has been used for this field.H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that 2 bd posiflush¿ pre-filled saline syringe experienced scale marking missing.The following information was provided by the initial reporter: found x02 syringes of batch no.2271556 without label.
 
Manufacturer Narrative
H6: investigation summary a device history record review was completed for provided material number 306575 and lot number 2271556.The review did not reveal any detected abnormalities during the production process that could have contributed to the reported defect and all quality tests were found to be within specification.To aid in the investigation of this issue, one (1) picture sample was provided for evaluation by our quality engineer team.Through examination of the picture, two (2) unopened posiflush sp syringes were identified with no barrel label.The picture sample was sufficient in confirming the reported defect.There is a vision system in place during the production process to detect issues with the barrel label, including the defect of missing label.Although no issues were identified during production, this incident most likely resulted after the vision system, due to a failure in the double rejection station.If a syringe has no label, the rejection station must reject it.
 
Event Description
It was reported that 2 bd posiflush¿ pre-filled saline syringe experienced scale marking missing.The following information was provided by the initial reporter: found x02 syringes of batch no.2271556 without label.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH¿ PRE-FILLED SALINE SYRINGE
Type of Device
SALINE, VASCULAR ACCESS FLUSH
Manufacturer (Section D)
BECTON DICKINSON, S.A.
cr mequinenza
s/n
fraga, huesca 22520
SP  22520
Manufacturer (Section G)
BECTON DICKINSON, S.A.
cr mequinenza
s/n
fraga, huesca 22520
SP   22520
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key16997026
MDR Text Key315919514
Report Number3002682307-2023-00135
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number306575
Device Lot Number2271556
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/28/2023
Initial Date FDA Received05/24/2023
Supplement Dates Manufacturer Received06/01/2023
Supplement Dates FDA Received06/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/28/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-